HSBC shares sink 6% on Hong Kong news! Is this a dip-buying opportunity?

HSBC shares have tumbled after plans to acquire Hang Seng Bank were poorly received. Royston Wild analyses the news.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Middle-aged black male working at home desk

Image source: Getty Images

While the FTSE 100 flirts with new highs, HSBC (LSE:HSBA) shares aren’t faring nearly as well on Thursday (9 October). At £10 per share, the index’s biggest bank has slumped 6% after planned M&A action in Hong Kong failed to inspire investors.

The company will spend $13.6bn to take full control of Hang Seng Bank, it says. The move supports its strategy of expanding in Hong Kong, which it identifies as a key growth market.

HSBC’s share price is still up an impressive 28% in the year to date. I’m wondering if today’s pullback represents an attractive dip-buying opportunity for investors to consider.

Shrewd move…

HSBC has long signalled that it sees its future in Asia. Recent asset sales in North America, Europe and Africa have expedited its changing geographic strategy, and boosted its investment capabilities in its high-performing Asian markets.

Today’s announcement doesn’t come as a surprise, then. Looking at Hong Kong specifically, HSBC says “it is best positioned to [grow] by strengthening the Hong Kong banking presence of both HSBC Asia Pacific and Hang Seng Bank.”

The bank’s also says it’s identified “an opportunity to create greater alignment across HSBC and Hang Seng Bank that may result in better operational leverage and efficiencies.”

… but at a price

The move itself makes good sense, then. But things get stickier when one considers what HSBC is paying to make the deal happen. The cost is huge.

Steve Clayton, analyst and head of equity funds at Hargreaves Lansdown, notes that “gaining control of Hang Seng comes at a premium, with HSBC offering to pay almost 30% above the previous market value of the listed minority shares… prompting some investors to argue that the deal will be dilutive to the group’s returns.”

HSBC will pay HK$155 per share for Hang Seng’s outstanding shares. That’s well above the closing price of $HK119 yesterday.

To add to investor unease, HSBC says it will halt buybacks of its own shares for the next three quarters to finance the deal. It hopes that stopping repurchases will bring its CET1 capital ratio back up to the target range of 14% to 14.5%.

Is HSBC a buy?

As a holder of HSBC shares myself, I can understand why the market has a dim view of the Hang Seng deal. In the short term, it’s easy to see why investors feel the move erodes shareholder value.

However, I haven’t been tempted to sell any or all of my own shares. I buy stocks to hold for the long haul. And my view of the FTSE 100 bank — as well as the eventual benefits of the Hang Seng takeover — remains upbeat over this sort of time horizon.

The outlook for HSBC remains clouded by tough economic conditions in China. However, over the long term things remain extremely promising as Asia experiences significant population growth and soaring income levels. Expansion in the region gives the bank additional scope to seize this opportunity.

HSBC’s share price drop today leaves it with a price-to-earnings (P/E) ratio of 11.1 times. Given the bank’s exceptional growth potential, I think this represents an attractive dip-buying opportunity to consider.

HSBC Holdings is an advertising partner of Motley Fool Money. Royston Wild has positions in HSBC Holdings. The Motley Fool UK has recommended HSBC Holdings. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »